Muneer Satter
Pharmaceutical Industry
Annexon Biosciences
New Zealand
Biography
Muneer A. Satter manages the Satter Foundation, a private family foundation. SIM has significant investments in several life sciences and medical technology companies. Mr. Satter is co-chairman and lead director of Vital Therapies, a publicly traded biotech company that has created an artificial liver for patients suffering from acute liver failure. He is chairman of Akebia Therapeutics, a publicly traded biotech company focused on the treatment of anemia. He is co-chairman of Aerpio Therapeutics, a biotech company with a TIE-2 activator for diabetic macular edema and vascular leaks. He is a director of Annexon which is a complement cascade pathway company focused on autoimmune and neurologic diseases. He is chairman and co-founder of Restorsea, a company which holds exclusive rights to a unique enzyme for an anti-aging cream. He is chairman of Linq3, a unique secure payment platform for lottery transactions.
Research Interest
=
